| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18258 R76648 |
Cornet - SSRIs, 2024 | Culture-proven neonatal sepsis | late pregnancy | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 1.44 [0.50;4.11] | 3/7,573 70/272,517 | 73 | 7,573 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5461 R24134 |
Levy, 2020 | Sepsis | throughout pregnancy | retrospective cohort | unexposed (general population or NOS) | Adjustment: No Matched Monotherapy: no or not specified | 3.04 [0.12;75.67] C | 1/82 0/82 | 1 | 82 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5430 R21363 |
Norby, 2016 | Neonatal verified infections | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 1.20 [1.00;1.60] | 91/17,736 2,539/718,533 | 2,630 | 17,736 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S12948 R49138 |
Engelstad (Controls unexposed, sick), 2014 | Presumed Sepsis | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No Monotherapy: SSRI only | 0.60 [0.14;2.57] C | 3/126 5/128 | 8 | 126 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5405 R16051 |
Wen, 2006 | Neonatal sepsis | 3 months (or more) before pregnancy or during pregnancy excluded | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Matched Monotherapy: no or not specified |
1.41 [0.65;3.06] excluded (exposition period) |
10/972 23/3,878 | 33 | 972 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 4 studies | 1.20 [0.95;1.50] | 2,712 | 25,517 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, sick;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded